Xconomy National

Archives

by in

Entry	Author	Date	Location
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M	Luke Timmerman	08/19/11	Seattle
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval	Luke Timmerman	06/08/11	Seattle
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News	Luke Timmerman	02/25/11	San Francisco
Pearl Hires New CEO	Luke Timmerman	02/24/11	San Francisco
Ocular Therapeutix Grabs $14M in New Round for Eye Therapies	Ryan McBride	02/03/11	Boston
Molecular Insight Pharma, Xconomy’s Neighbor, Faces Uncertain Future in Chapter 11	Ryan McBride	01/31/11	Boston
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010	Luke Timmerman	09/20/10	San Francisco
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior	Ryan McBride	09/20/10	Boston
CombinatoRx Becomes Zalicus	Erin Kutz	09/09/10	Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News	Erin Kutz	06/04/10	Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News	Erin Kutz	06/02/10	Boston
Covidien to Buy Ev3 for $2.6B	Ryan McBride	06/01/10	Boston
ImThera Medical Generating Buzz Over Neurostimulation for Sleep Apnea	Bruce V. Bigelow	03/05/10	San Diego
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News	Erin Kutz	03/05/10	Boston
CombinatoRx Grabs $40M with FDA Approval	Ryan McBride	03/02/10	Boston
Lantheus Medical Imaging Stakes Future on Innovation After Generic Hit to Key Product	Ryan McBride	02/16/10	Boston
Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year	Luke Timmerman	11/30/09	Seattle
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News	Rebecca Zacks	10/02/09	Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News	Ryan McBride	09/30/09	Boston
Covidien to Buy Aspect Medical for $210M	Robert Buderi	09/28/09	Boston
I-Therapeutix Raises $15M in Round Led by Polaris	Ryan McBride	06/19/09	Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News	Rebecca Zacks	10/01/08	Boston
Covidien Cuts Costs in All Four Business Units, Corporate	Luke Timmerman	09/29/08	Boston
The “Augmenix” Question: Can Amar Sawhney Do It Again with Latest Hydrogel Startup?	Ryan McBride	09/04/08	Boston
Corporate Life Sciences VCs on the Rise in New England—the List	Ryan McBride	09/03/08	Boston
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News	Rebecca Zacks	08/20/08	Boston
Covidien Launches Venture Arm	Ryan McBride	08/19/08	Boston
Page 1 of 1